Anti-cancer activated memory CD4+ T cells were significantly lower in all recurrence groups, and anti-cancer γδT cells were significantly lower and pro-cancerous regulatory T cells were significantly higher in Early and Late compared to Survivors. The gene discussed is CD4; the disease is cancer.